Results 21 to 30 of about 10,538,307 (206)

THE CLINICAL SIGNIFICANCE OF CARBOHYDRATE ANTIGEN 19-9 (CA19-9)

The Japanese Journal of Urology, 1993
For the purpose of evaluating the utility of CA19-9 determination in transitional cell cancer (TCC) of the urinary tract, its serum value, tissue level and, immunohistochemical study, and follow up study, with high serum value were examined in 43 cases with TCC and 13 cases of control. 1. Serum values were 19.1 U/ml in the control group and 198 U/ml in
Kohei Kurokawa, Jun Kurihara, Seiji Nakata, Yasusige Matsuo, Kazunori Ebihara, Hiroshi Kurihara, Takanori Suzuki, Kyoichi Imai, Hidetoshi Yamanaka, Keiji Suzuki   +9 more
openaire   +4 more sources

Increased carbohydrate antigen 19‐9 expression in a thymic neuroendocrine tumor

Thoracic Cancer, 2021
Here, we report a case of carbohydrate antigen (CA) 19‐9‐producing mediastinal neuroendocrine tumor (NET) (atypical carcinoid). A 54‐year‐old woman with no specific relevant medical history was referred to our hospital because of increased CA19‐9 (95.3 U/
Yuki Shimizu, Shintaro Kanda, Toshirou Fukushima, Takashi Kobayashi, Ryoichi Kondo, Tomonobu Koizumi   +5 more
doaj   +1 more source

Role of Urinary and Serum Carbohydrate Antigen 19-9 as a Biomarker in Diagnosis of Adult Giant Hydronephrosis [PDF]

Journal of Clinical and Diagnostic Research, 2016
Introduction: The most common cause of adult Giant Hydronephrosis (GH) is congenital Uretero-Pelvic Junction (UPJ) obstruction. Conventional imaging modalities, like Intravenous Urography (IVU) and Computed Tomography Urography (CTU) and radionuclide
Indraneel Banerjee, Vinay Tomar, Sher Singh Yadav, Nachiket Vyas, Suresh Yadav, Brijesh Sathian   +5 more
doaj   +1 more source

Biological Resectability in Colorectal Liver Metastases: A Nomogram-Based Continuous Risk Model to Define Borderline Disease. [PDF]

Ann Gastroenterol Surg
KRAS mutation demonstrated a prognostic impact according to primary tumor sidedness, independent of tumor morphology, in patients undergoing hepatectomy for colorectal liver metastases. A nomogram integrating biological and clinicopathological factors was developed to provide continuous biological risk assessment.
Umeda Y, Mitsuhashi T, Fuji T, Kojima T, Koujima T, Matsuda T, Satoh D, Inagaki M, Takagi K, Fujiwara T.   +9 more
europepmc   +2 more sources

Metastatc Gastric Adenocarcinoma Cancer With a Very High Serum Carbohydrate Antgen 19-9 Level: A Case Study

Case Reports in Clinical Practice, 2021
Carbohydrate Antigen 19-9 (CA19-9) is a tumor marker for the prognosis of colorectal and pancreatic cancers. The high level of this tumor marker in gastric cancer indicates the advanced stage and peritoneal metastasis of the tumor.
Alireza Jafarinezhad, Neda Aligolighasemabadi   +1 more
doaj   +1 more source

Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: Pretreatment levels or kinetics during chemotherapy? [PDF]

, 2007
Background: The carbohydrate antigen 19-9 (CA 19-9) is currently the most widely used serum tumor marker in pancreatic cancer (PC). CA 19-9 pretreatment levels as well as CA 19-9 kinetics during systemic chemotherapy can provide prognostic information ...
Holdenrieder, Stefan, Weckbach, Sabine, Schulz, Christoph, Boeck, Stefan, Heinemann, Volker, Stieber, Petra   +5 more
core   +1 more source

Prognostic value of normal levels of preoperative tumor markers in colorectal cancer

Scientific Reports, 2023
Carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 125 (CA125), and alpha-fetoprotein (AFP) are widely used tumor markers for colorectal cancer (CRC), but their clinical significance is unknown when the levels of ...
Guangming Ren, Ruikai Li, Gaozan Zheng, Kunli Du, Hanjun Dan, Hongze Wu, Xinyu Dou, Lili Duan, Zhenyu Xie, Liaoran Niu, Ye Tian, Jianyong Zheng, Fan Feng   +12 more
doaj   +1 more source

Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma

BMC Cancer, 2019
Background Growing evidence has indicated that tumor biomarkers, including cytokeratin 19 fragment antigen 21–1 (Cyfra21–1), carbohydrate antigen 19–9 (CA19–9), carbohydrate antigen 72–4 (CA72–4), carcinoembryonic antigen (CEA) and squamous cell ...
Yuchong Yang, Xuanzhang Huang, Likun Zhou, Ting Deng, Tao Ning, Rui Liu, Le Zhang, Ming Bai, Haiyang Zhang, Hongli Li, Yi Ba   +10 more
doaj   +1 more source

Next Generation Sequencing for the Differentiation of Benign and Malignant Biliary Strictures. [PDF]

Liver Int
ABSTRACT The differentiation between benign and malignant biliary strictures remains a significant clinical challenge. Recent studies have suggested that next generation sequencing (NGS) can improve the diagnostic accuracy. However, evidence on its performance in routine clinical practice is limited. Therefore, validation of the diagnostic value of NGS
Gillmeister A, Husman J, Schmelz R, Brückner S, Hampe J, Aust D, Zeissig S.   +6 more
europepmc   +2 more sources

High serum levels of CA 19-9 and CYFRA21-1 caused by renal pelvis urothelial carcinoma: a report of two cases

Journal of International Medical Research, 2021
Carbohydrate antigen 19-9 (CA19-9) and cytokeratin 19 fragment (CYFRA21-1) are widely used as tumor markers in clinical practice and are increased in many neoplasms.
Guolin Yin, Miaomiao Zhang, Bing Zhao, Zaixing Yang   +3 more
doaj   +1 more source